Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Sales and Divestitures (2019 - 2023)

INVO Fertility has reported Gains from Sales and Divestitures over the past 5 years, most recently at $16505.0 for Q3 2023.

  • Quarterly Gains from Sales and Divestitures fell 87.91% to $16505.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $16505.0 through Sep 2023, down 87.91% year-over-year, with the annual reading at $143174.0 for FY2022, 30.17% down from the prior year.
  • Gains from Sales and Divestitures was $16505.0 for Q3 2023 at INVO Fertility, roughly flat from $16505.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $1.2 million in Q1 2020 and troughed at $2083.0 in Q4 2019.
  • The 5-year median for Gains from Sales and Divestitures is $71312.5 (2020), against an average of $147945.1.
  • Year-over-year, Gains from Sales and Divestitures surged 2973.5% in 2020 and then plummeted 97.89% in 2021.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $2083.0 in 2019, then surged by 2973.5% to $64021.0 in 2020, then soared by 220.26% to $205031.0 in 2021, then plummeted by 30.17% to $143174.0 in 2022, then plummeted by 88.47% to $16505.0 in 2023.
  • Per Business Quant, the three most recent readings for IVF's Gains from Sales and Divestitures are $16505.0 (Q3 2023), $16505.0 (Q2 2023), and $179798.0 (Q1 2023).